leisure time -WSS

leisure time

author：knowledge 2025-09-27 22:06:20 - browse：57

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Florida health officials providing scant details on measles cases

focus

WSS

Pregnant women don't need prenatal multivitamins, study concludes

Bill would stop addiction treatment from triggering child abuse inquiry

Sana to lay off nearly a third of staff, de

Physician executives need more than on

Ozempic has benefits for kidney disease as well as diabetes

When women are denied an abortion, their children fare worse than peers

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

The public health thinking behind the CDC’s new Covid guidance

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Longer MASH drug regimen improved liver, Akero study finds

Hepatitis C has a cure — but many Americans still lack access to it

Ancient Greek ideas underpin modern concepts of pregnancy

After affirmative action ruling, medical educators look to 'holistic review'

Ancient Greek ideas underpin modern concepts of pregnancy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The future of health care in the House

Wikipedia

Readout Newsletter: BridgeBio, Akero, and human embryo models

Chan Zuckerberg Biohub Chicago to focus on inflammation

Why Talkspace is targeting Medicare, a tricky market

Immune cells and nerve overgrowth may explain recurring UTI pain

Why Charlie Gard's case is so disturbing to Americans

$1 billion proposal to grow Boston, Massachusetts biotech

hotspot

explore

focus

Wikipedia